Videos / Managing atherogenic dyslipidaemia and diabetic retinopathy in type 2 diabetes
Managing atherogenic dyslipidaemia and diabetic retinopathy in type 2 diabetes
Description
In this Product Explainer, Endocrinologist Prof Richard O’Brien explains the role of Fenofibrate in reducing the progression of diabetic retinopathy in patients with type 2 diabetes (5 mins).
NEXT LIVE Webcast
:
Days
:
Hours
:
Minutes
Seconds
Dr Deb Mills
Travel Medicine Update for General Practice
Dr Katherine Spira
Choosing the Right Migraine Preventative
Dr Jay Ramanathan, A/Prof David Sullivan, facilitated by A/Prof Ralph Audehm
Expert Panel – Atherosclerosis and Blood Lipid Management
A/Prof Daryl Efron
Autism – When & Who to Refer
Join us for the next free webcast for GPs and healthcare professionals
High quality lectures delivered by leading independent experts
Endocrinologist; Clinical Dean of Medicine, University of Melbourne, Austin Clinical School; Director of Graduate Programs, Melbourne Medical School; Senior Endocrinologist and Director, Lipid Service, Austin Health
